Category Archive for: ‘Cymbalta’

Lilly Pulls FDA Application For Cymbalta For Pain

Nov 28, 2008 CHICAGO (Reuters) – Eli Lilly and Co (LLY.N: Quote, Profile, Research, Stock Buzz) said on Friday it withdrew an application to market its anti-depressant Cymbalta for the management of chronic pain because U.S. health regulators raised questions about the drug’s effectiveness and dosing. Lilly said it made its decision to pull the supplemental New Drug Application for …

Read More

Cymbalta Eases Back Pain In Study

Mon Aug 25, 2008 NEW YORK (Reuters) – Eli Lilly and Co’s Cymbalta depression treatment significantly reduced chronic low back pain in a relatively small clinical trial, the company said on Monday. Data from the 236-patient trial, which lasted 13 weeks and compared the effectiveness of Cymbalta with placebos, were presented at the annual congress of the European Federation of …

Read More

Fibromyalgia Patients Fight Insurers Over Medication Coverage

Sunday, July 13, 2008By Steve Twedt, Pittsburgh Post-Gazette With the Food and Drug Administration’s approval of a second fibromyalgia medication last month, you’d think the nation’s estimated 10 million acute pain fibromyalgia sufferers would be delighted. Not quite. While welcoming any new treatment, patients also know that insurance companies have been slow to cover Lyrica, which won FDA approval a …

Read More

Cymbalta Gets FDA Approval For Fibromyalgia

Eli Lilly antidepressant approved for new useBUSINESSWEEKThe Associated Press June 16, 2008, 4:41PM ETEli Lilly antidepressant approved for new use Eli Lilly and Co. said Monday it received Food and Drug Administration approval to expand the use of its fastest-growing drug, the antidepressant Cymbalta. Regulators approved Cymbalta to treat fibromyalgia, a chronic pain disorder. The drug already is approved for …

Read More